Beta Bionics, Inc.

Beta Bionics, Inc.(BBNX)のニュースとイベント

$17.850

-2.954 (-16.55%)終値時点

BBNX のニュース

BBNX のイベント

10/27 16:30

Company Reports Q3 Revenue of $35.51M

Reports Q3 revenue $35.51M, consensus $34.58M. The company said, "New patient starts increased by a mid-single digit percentage versus the second quarter of 2026."

10/27 16:30

Company Expects $8.5M Revenue Deferral in Q4 2026

Consensus $124.36M. The company said, "Revenue guidance reflects a potential revenue deferral impact of up to $8.5 million in the fourth quarter of 2026 as new prospective iLet users could choose to await the launch of Mint. During the full year 2027, the Company expects Mint to recapture any revenue lost in the fourth quarter of 2026."

9/22 08:00

Beta Bionics Partners with Senseonics for New System Launch

Beta Bionics (BBNX) announced a partnership to integrate the iLet Bionic Pancreas and mint automated insulin delivery systems with Senseonics' (SENS) Eversense 365 continuous glucose monitoring system. Commercial launch of the integrated iLet and Eversense 365 system is expected in the fourth quarter of 2026, at which time Beta Bionics expects iLet to support the most CGM manufacturer options of any AID system.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める